loadpatents
name:-0.01143217086792
name:-0.0040199756622314
name:-0.0012869834899902
Ramnarayan; Kalyanaraman Patent Filings

Ramnarayan; Kalyanaraman

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ramnarayan; Kalyanaraman.The latest application filed is for "highly 6-substituted -2,4-diaminopyrimidines as inhibitors of anthrax".

Company Profile
0.3.7
  • Ramnarayan; Kalyanaraman - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Highly 6-substituted -2,4-diaminopyrimidines As Inhibitors Of Anthrax
App 20150065509 - Barrow; William ;   et al.
2015-03-05
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications
App 20060217894 - Ramnarayan; Kalyanaraman ;   et al.
2006-09-28
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications
App 20060141480 - Ramnarayan; Kalyanaraman ;   et al.
2006-06-29
Organosulfur inhibitors of tyrosine phosphatases
App 20050065118 - Wang, Jing ;   et al.
2005-03-24
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications
App 20050004766 - Ramnarayan, Kalyanaraman ;   et al.
2005-01-06
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications
App 20030158672 - Ramnarayan, Kalyanaraman ;   et al.
2003-08-21
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
Grant 6,541,498 - Chan , et al. April 1, 2
2003-04-01
Inhibitors of anthrax lethal factor activity
Grant 6,436,933 - Rideout , et al. August 20, 2
2002-08-20
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
App 20010036958 - Chan, Ming Fai ;   et al.
2001-11-01
Sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,571,821 - Chan , et al. November 5, 1
1996-11-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed